Cargando…
PROX1 Inhibits PDGF-B Expression to Prevent Myxomatous Degeneration of Heart Valves
BACKGROUND: Cardiac valve disease is observed in 2.5% of the general population and 10% of the elderly people. Effective pharmacological treatments are currently not available, and patients with severe cardiac valve disease require surgery. PROX1 (prospero-related homeobox transcription factor 1) an...
Autores principales: | Ho, Yen-Chun, Geng, Xin, O’Donnell, Anna, Ibarrola, Jaime, Fernandez-Celis, Amaya, Varshney, Rohan, Subramani, Kumar, Azartash-Namin, Zheila J., Kim, Jang, Silasi, Robert, Wylie-Sears, Jill, Alvandi, Zahra, Chen, Lijuan, Cha, Boksik, Chen, Hong, Xia, Lijun, Zhou, Bin, Lupu, Florea, Burkhart, Harold M., Aikawa, Elena, Olson, Lorin E., Ahamed, Jasimuddin, López-Andrés, Natalia, Bischoff, Joyce, Yutzey, Katherine E., Srinivasan, R. Sathish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487359/ https://www.ncbi.nlm.nih.gov/pubmed/37555328 http://dx.doi.org/10.1161/CIRCRESAHA.123.323027 |
Ejemplares similares
-
Therapeutic CCR2 Blockade Prevents Inflammation and Alleviates Myxomatous Valve Disease in Marfan Syndrome
por: Xu, Na, et al.
Publicado: (2022) -
Beneficial Effects of Mineralocorticoid Receptor Antagonism on Myocardial Fibrosis in an Experimental Model of the Myxomatous Degeneration of the Mitral Valve
por: Ibarrola, Jaime, et al.
Publicado: (2020) -
Complementary Wnt Sources Regulate Lymphatic Vascular Development via PROX1-Dependent Wnt/β-Catenin Signaling
por: Cha, Boksik, et al.
Publicado: (2018) -
Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease
por: Garcia-Pena, Amaia, et al.
Publicado: (2021) -
YAP and TAZ maintain PROX1 expression in the developing lymphatic and lymphovenous valves in response to VEGF-C signaling
por: Cha, Boksik, et al.
Publicado: (2020)